Mobocertinib in EGFR exon 20 insertion-positive metastatic NSCLC patients with disease control on prior EGFR TKI therapy Meeting Abstract


Authors: Spira, A.; Ramalingam, S.; Neal, J.; Piotrowska, Z.; Mekhail, T.; Tsao, A.; Gentzler, R.; Riely, G.; Bazhenova, L.; Gadgeel, S.; Nguyen, D.; Johnson, M.; Vincent, S.; Jin, S.; Griffin, C.; Bunn, V.; Lin, J.; Churchill, E.; Mehta, M.; Janne, P.
Abstract Title: Mobocertinib in EGFR exon 20 insertion-positive metastatic NSCLC patients with disease control on prior EGFR TKI therapy
Meeting Title: 2021 World Conference on Lung Cancer
Keywords: inhibitor; non-small cell lung cancer; egfr tyrosine kinase; exon20 insertion
Journal Title: Journal of Thoracic Oncology
Volume: 16
Issue: 10 Suppl.
Meeting Dates: 2021 Sep 8-14
Meeting Location: Virtual event
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2021-10-01
Start Page: S873
End Page: S874
Language: English
ACCESSION: WOS:000709606500081
PROVIDER: wos
DOI: 10.1016/j.jtho.2021.08.082
Notes: Meeting Abstract: OA15.01 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gregory J Riely
    602 Riely